Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,910 | 330 | 95.4% |
| Education | $283.42 | 4 | 4.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,543 | 95 | $0 (2024) |
| Janssen Biotech, Inc. | $952.47 | 41 | $0 (2024) |
| Lilly USA, LLC | $730.18 | 45 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $384.97 | 16 | $0 (2024) |
| Amgen Inc. | $310.63 | 15 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $295.99 | 15 | $0 (2024) |
| PFIZER INC. | $250.31 | 15 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $249.65 | 12 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $223.76 | 11 | $0 (2024) |
| LEO Pharma Inc. | $165.15 | 10 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,346 | 110 | ABBVIE INC. ($573.62) |
| 2023 | $1,978 | 111 | ABBVIE INC. ($404.41) |
| 2022 | $1,583 | 103 | ABBVIE INC. ($511.27) |
| 2021 | $210.96 | 9 | Stemline Therapeutics Inc. ($83.59) |
| 2017 | $74.99 | 1 | Janssen Biotech, Inc. ($74.99) |
All Payment Transactions
334 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Inflammation | ||||||
| 12/16/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $29.48 | General |
| Category: DERMATOLOGY | ||||||
| 12/11/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $38.20 | General |
| Category: Immunology | ||||||
| 12/03/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Immunology | ||||||
| 12/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $27.42 | General |
| Category: Inflammation | ||||||
| 11/25/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $25.29 | General |
| Category: Immunology | ||||||
| 11/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.56 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $2.60 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $37.88 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $21.69 | General |
| Category: DERMATOLOGY | ||||||
| 11/11/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Immunology | ||||||
| 10/31/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $35.91 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: Immunology | ||||||
| 10/22/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Immunology | ||||||
| 10/17/2024 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 10/16/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Immunology | ||||||
| 10/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.90 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $37.12 | General |
| Category: IMMUNOLOGY | ||||||
| 10/01/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $17.77 | General |
| 09/30/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Odomzo (Drug), BLU-U | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,232 | 2,542 | $283,936 | $86,319 |
| 2022 | 13 | 795 | 1,578 | $174,393 | $54,411 |
| 2021 | 9 | 338 | 535 | $48,407 | $17,801 |
| 2020 | 11 | 690 | 1,261 | $98,902 | $38,928 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 249 | 351 | $44,226 | $19,644 | 44.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 192 | 243 | $44,469 | $14,006 | 31.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 53 | 82 | $28,864 | $9,201 | 31.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 103 | 123 | $22,632 | $8,077 | 35.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 200 | 266 | $33,250 | $7,860 | 23.6% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 23 | 25 | $12,955 | $5,445 | 42.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 162 | 1,124 | $47,208 | $5,203 | 11.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 85 | 142 | $14,200 | $5,063 | 35.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 59 | $11,505 | $4,993 | 43.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 44 | 44 | $8,800 | $2,532 | 28.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 42 | 44 | $3,564 | $1,337 | 37.5% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 13 | 14 | $5,642 | $1,274 | 22.6% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 12 | 12 | $2,760 | $1,111 | 40.3% |
| 69100 | Biopsy of ear | Office | 2023 | 12 | 13 | $3,861 | $573.08 | 14.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 147 | 178 | $32,574 | $10,689 | 32.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 138 | 174 | $21,924 | $9,968 | 45.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 116 | 156 | $19,500 | $4,869 | 25.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 43 | 52 | $10,140 | $4,404 | 43.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 24 | 40 | $14,080 | $4,337 | 30.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 49 | 55 | $10,120 | $4,308 | 42.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 64 | 98 | $9,800 | $3,499 | 35.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 49 | 49 | $9,800 | $3,164 | 32.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 94 | 700 | $29,400 | $3,136 | 10.7% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 13 | 13 | $6,760 | $2,603 | 38.5% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 15 | 16 | $3,680 | $1,482 | 40.3% |
About Dr. Tandy Repass, MD
Dr. Tandy Repass, MD is a Dermatology healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2009. The National Provider Identifier (NPI) number assigned to this provider is 1043444219.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tandy Repass, MD has received a total of $6,193 in payments from pharmaceutical and medical device companies, with $2,346 received in 2024. These payments were reported across 334 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($5,910).
As a Medicare-enrolled provider, Repass has provided services to 3,055 Medicare beneficiaries, totaling 5,916 services with total Medicare billing of $197,459. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Other Specialties Student in an Organized Health Care Education/Training Program, Dermatology
- Location Lexington, KY
- Active Since 05/04/2009
- Last Updated 09/20/2022
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1043444219
Products in Payments
- SKYRIZI (Biological) $901.27
- TREMFYA (Drug) $862.49
- TALTZ (Drug) $684.22
- RINVOQ (Biological) $427.97
- Sotyktu (Drug) $321.18
- Otezla (Drug) $296.59
- SPEVIGO (Drug) $260.76
- DUPIXENT (Biological) $242.92
- EUCRISA (Drug) $228.60
- HUMIRA (Biological) $204.89
- ADBRY (Biological) $165.15
- OPZELURA (Drug) $123.55
- Odomzo (Drug) $106.93
- Winlevi (Drug) $103.00
- LIBTAYO (Biological) $95.31
- VTAMA (Drug) $95.03
- Erivedge (Biological) $94.47
- Klisyri (Drug) $94.10
- COSENTYX (Drug) $91.23
- ELZONRIS (Drug) $83.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Lexington
Dr. Dana Black, M.d, M.D
Dermatology — Payments: $16,936
Dr. Jonathan Keeling, D.o, D.O
Dermatology — Payments: $13,957
Gerald Elliott, M.d, M.D
Dermatology — Payments: $13,657
Carol Thompson, Md, MD
Dermatology — Payments: $9,859
Dr. Erika Music, Md, MD
Dermatology — Payments: $8,825
Tessa Mullins, D.o, D.O
Dermatology — Payments: $7,458